Home> Products> potential discounts

{ "products": [ { "_id": "6943af86161ad9de85f42b10", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Imatinib IP 400mg", "description": "IMATIFLOW 400, containing Imatinib IP 400mg, represents a breakthrough in targeted cancer therapy, offering patients a precise weapon against specific malignancies. This oral medication belongs to the class of tyrosine kinase inhibitors, revolutionizing treatment for conditions once deemed challenging to manage. By blocking abnormal proteins that fuel cancer cell growth, IMATIFLOW 400 helps restore normal cellular function and improves quality of life for many users.​\n\nProduct Overview\nIMATIFLOW 400 is a branded formulation of Imatinib mesylate 400mg, produced to high pharmaceutical standards for consistent efficacy and bioavailability. Each tablet delivers the active ingredient in a film-coated form, designed for once-daily administration with food to enhance absorption and minimize gastrointestinal upset. Developed for adult patients, it targets cancers driven by dysregulated tyrosine kinases like BCR-ABL, c-KIT, and PDGFR, making it a cornerstone in modern oncology protocols.​\n\nThe medication's mechanism hinges on competitive inhibition at the ATP-binding site of these kinases, halting downstream signaling pathways that promote uncontrolled proliferation, survival, and metastasis of malignant cells. Unlike traditional chemotherapy, which broadly attacks dividing cells, IMATIFLOW 400 spares most healthy tissues, leading to a more favorable safety profile. Clinical data from pivotal trials underscore its role as first-line therapy, with high response rates observed within months of initiation.​\n\nPrimary Uses\nIMATIFLOW 400 excels in treating chronic myeloid leukemia (CML), particularly in the chronic phase where it induces deep molecular responses in over 80% of patients. It suppresses the Philadelphia chromosome-positive cells hallmark of CML by inhibiting the BCR-ABL fusion protein, dramatically extending progression-free survival. For newly diagnosed patients, standard dosing starts at 400mg daily, often achieving complete cytogenetic remission.​\n\nIn gastrointestinal stromal tumors (GIST), IMATIFLOW 400 targets KIT or PDGFRA mutations, shrinking unresectable tumors and delaying progression in advanced cases. The recommended dose remains 400mg once daily, with potential escalation to 600-800mg for resistant strains, as per oncology guidelines. It also finds application in dermatofibrosarcoma protuberans (DFSP), aggressive systemic mastocytosis, and certain myelodysplastic syndromes, broadening its utility in precision medicine.​\n\nHealthcare providers monitor response via PCR for BCR-ABL transcripts in CML or imaging for GIST, adjusting therapy based on milestones like major molecular response. Patients with Ph+ acute lymphoblastic leukemia (ALL) may receive it adjunctively, enhancing outcomes when combined with chemotherapy. Overall, IMATIFLOW 400 transforms these diseases from fatal to chronically manageable.​\n\nKey Benefits\nOne standout benefit of IMATIFLOW 400 is its oral convenience, eliminating the need for frequent hospital visits associated with infusions. Response rates exceed 90% in early CML, with many patients achieving treatment-free remission after sustained deep responses, a paradigm shift from interferon-era therapies.​\n\nTumor control in GIST prevents life-threatening complications like bowel obstruction, improving survival from months to years. Its specificity reduces severe toxicities, allowing patients to maintain daily activities, work, and social engagements with minimal disruption. Long-term studies report 10-year survival rates above 80% in CML, underscoring durable efficacy.​\n\nAdditional advantages include cost-effectiveness over biologics and compatibility with supportive care like hydroxyurea for cytoreduction. Fluid retention, while common, responds well to diuretics, preserving cardiac function. For Indian patients, accessible pricing via brands like IMATIFLOW 400 supports equitable care in resource-limited settings.​\n\nPotential Side Effects\nWhile generally well-tolerated, IMATIFLOW 400 can cause edema (swelling in legs or face) in up to 70% of users, managed by dose reduction or supportive measures. Gastrointestinal issues like nausea, vomiting, and diarrhea affect 40-50%, often resolving with antiemetics and dietary adjustments.​\n\nMusculoskeletal pain, cramps, and fatigue occur frequently, alongside rash and abdominal discomfort. Hematologic effects include neutropenia or thrombocytopenia, necessitating regular blood counts. Rare but serious risks involve liver enzyme elevation, heart failure, or hemorrhage; prompt reporting of symptoms like shortness of breath or yellowing skin is crucial.​\n\nAvoid grapefruit juice, as it elevates drug levels, and inform doctors of concurrent medications like CYP3A4 inhibitors. Pregnancy category D status advises contraception, with monitoring for growth retardation in exposed fetuses. Dizziness may impair driving, so caution is essential during initial weeks.​\n\nDosage and Administration Guidelines\nSwallow IMATIFLOW 400 whole with a meal and full glass of water to optimize pharmacokinetics and reduce esophageal irritation. The standard adult dose for CML chronic phase is 400mg daily; for accelerated phase or blast crisis, 600mg. GIST dosing mirrors 400mg, titrated based on tolerance and response.​\n\nRenal or hepatic impairment requires dose adjustments—reduce to 300-400mg in moderate cases. Do not crush or chew tablets. Missed doses should be taken promptly unless near the next, avoiding doubles. Long-term use demands quarterly monitoring of CBC, liver function, and ECG.​\n\nPrecautions and Interactions\nPatients with a cardiac history need baseline echocardiograms, as QT prolongation or effusion risks exist. Drug interactions abound: St. John's wort induces metabolism, reducing efficacy; ketoconazole boosts levels. Vaccines, especially live ones, are contraindicated during therapy.​\n\nRegular dermatologic checks mitigate skin cancer risk from prolonged use. Hydration combats fluid retention, and low-salt diets aid management. Steris Healthcare emphasizes patient education via counseling on adherence for optimal outcomes.​\n\nConclusion\nIMATIFLOW 400 (Imatinib IP 400mg) stands as a testament to targeted therapy's power, offering robust control over CML, GIST, and related cancers with a balance of efficacy and manageability. Its benefits in prolonging life and enhancing daily functioning far outweigh transient side effects for most when monitored diligently. Consult oncologists for personalized plans, ensuring this innovative treatment maximizes hope and health in the fight against cancer.", "price": 1827.0, "discountamount": 540.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2249, "imageuri": "https://productimages.withfloats.com/actual/6943b026ca1b0dcfc6c37820.png", "tileimageuri": "https://productimages.withfloats.com/tile/6943b026ca1b0dcfc6c37820.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-18T07:38:46.766Z", "updatedon": "2025-12-18T07:41:25.851Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/imatinib-ip-400mg/2249", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "IMATIFLOW 400", "category": "NEPHROLOGYRANGE", "tags": [ "Imatinib IP 400mg", "offering robust control over CML.", "related cancers with a balance of efficacy and manageability.", "innovative treatment maximizes hope and health in the fight against cancer.", "cancer therapy.", "fuel cancer cell growth.", "chemotherapy." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "693c0c9c0c30ac5c9f8203b4", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Isosorbide Mononitrate IP 30mg Tablets", "description": "CARDULES ISMN SR 30 tablets provide sustained-release Isosorbide Mononitrate IP 30mg, a nitrate medication designed for long-term management of angina in patients with coronary artery disease. This formulation from Steris Healthcare Pvt Ltd ensures steady vasodilation to improve heart blood flow and reduce chest pain episodes. It supports daily activities by minimizing oxygen demand on the heart muscle.​\nProduct Overview\nCARDULES ISMN SR 30 contains Isosorbide Mononitrate IP 30mg in a sustained-release matrix, allowing once-daily dosing for consistent therapeutic levels over 12-24 hours. The tablet's extended-release technology prevents peak-trough fluctuations common in immediate-release forms, promoting better patient compliance. Each film-coated tablet delivers precise bioavailability, with the active metabolite nitric oxide activating guanylate cyclase to boost cyclic GMP, relaxing vascular smooth muscle primarily in veins.​\n\nThis mechanism reduces preload (venous return to the heart) and afterload (arterial resistance), easing cardiac workload without significantly affecting heart rate. Unlike short-acting nitrates for acute relief, CARDULES ISMN SR 30 targets prophylaxis in chronic stable angina, often prescribed alongside beta-blockers or calcium channel blockers. Available in strips of 10 tablets, it undergoes rigorous quality testing at Steris facilities to meet IP standards, ensuring purity and stability.​\n\nKey Uses\nCARDULES ISMN SR 30 primarily prevents angina pectoris in coronary artery disease, where narrowed vessels limit oxygen supply during exertion. Patients experience fewer chest pain attacks during walking, climbing stairs, or stress.​\n\nIt manages chronic stable angina by enhancing myocardial perfusion, suitable for long-term therapy in adults over 18. Healthcare providers may use it adjunctively for coronary spasm or post-myocardial infarction prophylaxis to stabilize symptoms.​\n\nIn select cases, it aids heart failure management by offloading the heart, though not as monotherapy. Always initiate under cardiology supervision with dose titration to tolerance.​\n\nMajor Benefits\nThe sustained-release profile offers 24-hour protection with single morning dosing, improving adherence and lifestyle quality for active patients. It boosts exercise tolerance by 20-30% in trials, allowing longer physical efforts without angina onset.​\n\nBy dilating vessels, it decreases ischemia risk, potentially lowering hospitalization rates for acute episodes. Compared to placebo, users report halved attack frequency within weeks, enhancing daily productivity and emotional well-being.​\n\nBenefit\tMechanism\tPatient Outcome\nAngina Prevention\tVasodilation reduces preload/afterload ​\tFewer attacks, better exertion capacity\nSteady Relief\tSR formulation maintains levels ​\tOnce-daily convenience, no fluctuations\nHeart Protection\tImproves O2 delivery ​\tReduced ischemia, enhanced QoL\nCompliance Boost\tSimple regimen ​\tHigher adherence vs multiple doses\nAdditional perks include minimal impact on blood pressure in normotensives and compatibility with anti-anginals, making it versatile in combo therapy.\n\nPotential Side Effects\nCommon effects include headache (dose-related, often transient in first week), dizziness, or flushing due to vasodilation—hydrate and rise slowly to manage. Gastrointestinal upset like nausea occurs in 5-10% initially.​\n\nOrthostatic hypotension risks fainting, especially early; avoid alcohol or other vasodilators. Rare serious issues encompass severe hypotension, tachycardia, or methemoglobinemia with overdose—monitor blood pressure regularly.​\n\nAllergic reactions (rash, itching) or vision changes warrant discontinuation. Contraindicated in hypotension, glaucoma, or recent PDE5 inhibitor use; caution in anemia or hypothyroidism.​\n\nDosage Guidelines\nStart with 30mg once daily upon waking, swallowed whole without crushing. Titrate to 60mg if tolerated after 3-7 days, max 120mg/day. Take on empty stomach for optimal absorption; avoid late dosing to prevent nocturnal headaches.​\n\nAdjust for elderly or renal/hepatic impairment. Tolerance may develop—nitrate-free interval (evening) helps sustain efficacy. Store below 30°C.​\nConclusion\nCARDULES ISMN SR 30 empowers angina patients with reliable, once-daily prevention, restoring confidence in routine activities under Steris Healthcare's quality assurance. Its targeted vasodilation balances efficacy and tolerability for sustained heart health", "price": 65.0, "discountamount": 19.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2243, "imageuri": "https://productimages.withfloats.com/actual/693c0ca6391a3fa44b0608d8.png", "tileimageuri": "https://productimages.withfloats.com/tile/693c0ca6391a3fa44b0608d8.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-12T12:37:48.92Z", "updatedon": "2025-12-12T12:37:48.92Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/isosorbide-mononitrate-ip-30mg-tablets/2243", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CARDULES ISMN SR 30", "category": "", "tags": [ "Isosorbide Mononitrate IP 30mg Tablets", "coronary artery disease", "heart blood flow and reduce chest pain episodes", "oxygen demand on the heart muscle", "relaxing vascular smooth muscle primarily in veins" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "693c05831844c6739ab3e83a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Mefenamic Acid and Paracetamol Suspension", "description": "METAPECT MF KID SUSPENSION stands out as a specialized formulation from Steris Healthcare Pvt Ltd, blending Mefenamic Acid, a non-steroidal anti-inflammatory drug (NSAID), with Paracetamol, a widely used analgesic and antipyretic. Typically available in a 60ml bottle with child-friendly flavoring, it contains precise concentrations like 100mg Mefenamic Acid and 250mg Paracetamol per 5ml serving, ensuring accurate dosing via the included measuring cup. This sugar-free or low-sugar variant minimizes dental risks while providing rapid absorption for faster onset compared to solid forms. Manufactured under stringent quality controls, it supports pediatric care by addressing inflammation at its source through COX enzyme inhibition, which curbs prostaglandin production responsible for pain signals and fever response.​\n\nThe suspension's dual-action mechanism sets it apart: Paracetamol targets the brain's hypothalamus to regulate body temperature and elevate pain thresholds, while Mefenamic Acid reduces tissue swelling and inflammatory mediators. This synergy makes METAPECT MF KID SUSPENSION more effective than single-ingredient options for multifaceted symptoms. Healthcare professionals often recommend it for short-term use in infants over six months and children, always under medical guidance to match age and weight-based dosages.​\n\nKey Uses\nMETAPECT MF KID SUSPENSION excels in managing fever associated with viral infections, teething, or post-vaccination reactions. It swiftly lowers elevated temperatures, promoting comfort and better sleep for restless kids.​\n\nFor pain relief, it tackles mild to moderate discomfort from headaches, toothaches, earaches, and sore throats common during colds or flu. Caregivers report noticeable easing of symptoms within 30-60 minutes, allowing children to resume play or eat without distress.​\n\nAdditionally, it soothes body aches, muscle strains from minor injuries, or joint pains in growing kids. In cases of post-surgical recovery or inflammatory episodes, it provides reliable support without the need for stronger opioids.​\n\nMajor Benefits\nThe primary benefit lies in its comprehensive symptom control, combining antipyretic, analgesic, and anti-inflammatory effects for holistic relief. Children experience reduced fever, less pain, and diminished swelling, leading to improved appetite and activity levels.​\n\nIts liquid suspension format ensures easy administration—no choking risks—and precise dosing prevents under- or overdosing. Flavored options like mango enhance compliance, turning medicine time into a less daunting routine for picky eaters.​\n\nCompared to alternatives, METAPECT MF KID SUSPENSION offers quicker bioavailability due to its oral liquid state, ideal for emergencies like high fever spikes at night. Long-term, it supports faster recovery by minimizing inflammation, potentially shortening illness duration when used as directed.​\n\nBenefit\tDescription:\tAdvantage over Single Agents\nFever Reduction\tLowers temperature via hypothalamic action ​\tFaster than Paracetamol alone\nPain Relief\tBlocks pain signals and prostaglandins. ​\tSuperior for inflammatory pain\nAnti-Inflammatory\tReduces swelling in tissues ​\tAddresses root cause, not just symptoms\nEasy Dosing\tLiquid with dropper for accuracy ​\tChild-friendly, no splitting tablets\nPotential Side Effects\nWhile generally well-tolerated, METAPECT MF KID SUSPENSION may cause mild gastrointestinal issues like nausea, vomiting, stomach pain, or indigestion in some children, especially if taken on an empty stomach. Administering with food can mitigate this.​\n\nLess common effects include drowsiness, dizziness, or allergic reactions such as rashes, itching, or swelling—seek immediate medical help if these occur. Prolonged use risks liver strain from Paracetamol or kidney concerns from Mefenamic Acid, so adhere strictly to prescribed durations.​\nRarely, it might lead to diarrhea, headache, or elevated liver enzymes. Monitoring is key; consult a doctor for persistent symptoms or in kids with pre-existing conditions like asthma or ulcers.​\n\nDosage Guidelines\nFollow pediatrician-recommended doses based on weight: typically 5-10ml every 6-8 hours, not exceeding 4 doses daily. Shake well before use and store below 30°C away from light.​\nAvoid in neonates under 6 months or those with hypersensitivity. Hydration and diet play roles in efficacy—pair with plenty of fluids.​\nConclusion\nMETAPECT MF KID SUSPENSION empowers parents with a dependable tool for childhood pain and fever, blending efficacy, safety, and convenience under Steris Healthcare's trusted banner. Quick relief restores normalcy, but professional oversight ensures optimal outcomes.", "price": 57.0, "discountamount": 18.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2241, "imageuri": "https://productimages.withfloats.com/actual/693c05860443b6722a4db029.png", "tileimageuri": "https://productimages.withfloats.com/tile/693c05860443b6722a4db029.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-12T12:07:31.874Z", "updatedon": "2025-12-12T12:07:31.874Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/mefenamic-acid-and-paracetamol-suspension/2241", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "METAPECT MF KID SUSPENSION", "category": "PEDIATRICS", "tags": [ "Mefenamic Acid and Paracetamol Suspension", "Paracetamol", "Mefenamic Acid and 250mg Paracetamol per 5ml serving", "COX enzyme inhibition", "pain and fever", "Pain Relief" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6937d6192800555f6696845e", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Naltrexone Hydrochloride IP 50 mg", "description": "Naltrexone Hydrochloride IP 50 mg, marketed under the brand name NALTREXON 50, is a prescription medication primarily used in the management of opioid and alcohol dependence. This potent pharmaceutical agent plays a crucial role in addiction treatment programs by helping individuals reduce or eliminate their reliance on addictive substances. Below is an in-depth description of the product, its uses, key benefits, possible side effects, and a concluding overview.\n\nProduct Description\nNALTREXON 50 contains Naltrexone Hydrochloride as its active ingredient, formulated as an immediate-release tablet with a strength of 50 mg per tablet. Naltrexone is an opioid antagonist, meaning it works by blocking the opioid receptors in the brain. By binding to these receptors without activating them, Naltrexone prevents opioids from producing their euphoric and sedative effects, which are often responsible for addiction.\nPharmacologically, Naltrexone Hydrochloride belongs to the class of medications known as opioid antagonists, specifically targeting mu, kappa, and delta opioid receptors. Its chemical composition and formulation comply with the Indian Pharmacopoeia (IP) standards, ensuring high quality and purity that meet regulatory guidelines.\n\nNALTREXON 50 is indicated for adults who are already detoxified from opioids or alcohol and are motivated to maintain abstinence from these substances. It supports addiction recovery by reducing cravings and diminishing the rewarding effects if relapse occurs.\n\nUses of NALTREXONE 50\nNALTREXONE 50 is primarily prescribed for two major therapeutic purposes:\n\nAlcohol dependence management: It helps reduce the desire to consume alcohol and lowers the risk of relapse by blocking alcohol’s rewarding effects in the brain.\n\nOpioid dependence treatment: Naltrexone aids in preventing relapse by blocking the euphoric and sedative effects induced by opioid drugs like heroin, morphine, and prescription painkillers.\n\nThe medication is typically administered as part of a comprehensive addiction treatment plan that includes counseling, behavioral therapies, and support groups. It is essential that the patient is opioid-free for at least 7 to 10 days before starting Naltrexone to avoid precipitating withdrawal symptoms.\n\nKey Benefits\nReduces cravings and relapse: By blocking opioid receptors, NALTREXON 50 reduces cravings and diminishes the pleasure derived from alcohol or opioid consumption, which helps patients stay abstinent.\n\nNon-addictive: Unlike some addiction treatments that contain opioids, Naltrexone is non-addictive and does not produce tolerance or dependence.\n\nSupports long-term recovery: When combined with behavioral therapy, Naltrexone enhances the likelihood of successful long-term abstinence from alcohol and opioids.\n\nImproves quality of life: Patients taking NALTREXONE 50 often experience improved emotional stability, better social functioning, and enhanced physical health compared to ongoing substance use.\n\nOral administration: As an oral tablet, Naltrexone is easy to administer, improving patient compliance.\n\nReduces overdose risk: By blocking the euphoric effects of opioids, it reduces the temptation to use high doses, thereby decreasing the risk of overdose.\n\nSide Effects\nLike all medications, NALTREXON 50 can cause side effects, although not everyone experiences them. Common side effects associated with Naltrexone Hydrochloride include:\n\nNausea and vomiting: These digestive issues are most frequent during the initial treatment phase but often subside with continued use.\n\nHeadache: Mild to moderate headaches may occur.\n\nDizziness and fatigue: Some patients report feeling dizzy or tired, particularly in the beginning.\n\nInsomnia: Difficulty sleeping or altered sleep patterns may be experienced.\n\nAnxiety or nervousness: Some individuals may feel anxious or agitated.\n\nJoint or muscle pain: Muscle aches and joint discomfort can occasionally occur.\n\nLiver function changes: Very rarely, Naltrexone may lead to elevations in liver enzymes; therefore, monitoring liver function tests during treatment is recommended.\n\nSevere side effects or allergic reactions are uncommon but require immediate medical attention. These include symptoms such as rash, swelling, difficulty breathing, or severe abdominal pain.\n\nIt is crucial for patients to inform their healthcare provider about any pre-existing liver conditions, prescribed or over-the-counter medications, and any history of opioid- or alcohol-related health issues before starting therapy.\n\nConclusion\nNALTREXON 50, containing Naltrexone Hydrochloride IP 50 mg, is a highly effective medication designed to aid in the treatment of alcohol and opioid dependence. Its action as an opioid antagonist helps block the pleasurable effects of these substances, reduce cravings, and diminish relapse risks. When used responsibly as part of a multidisciplinary treatment approach that incorporates counseling and behavioral therapies, NALTREXON 50 significantly enhances the chances of sustained recovery and improved quality of life.\n\nThough generally well-tolerated, users should be aware of potential side effects and consult healthcare providers regularly to ensure safety throughout the course of treatment. With careful medical oversight and patient commitment, NALTREXON 50 is a valuable tool in the fight against substance dependence, offering hope for individuals seeking freedom from addiction.", "price": 745.0, "discountamount": 223.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2240, "imageuri": "https://productimages.withfloats.com/actual/6937d61c3811575f667dea96.png", "tileimageuri": "https://productimages.withfloats.com/tile/6937d61c3811575f667dea96.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-09T07:56:09.144Z", "updatedon": "2025-12-09T07:56:09.144Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/naltrexone-hydrochloride-ip-50-mg/2240", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NALTREXON 50", "category": "NEUROLOGY RANGE", "tags": [ "Naltrexone Hydrochloride IP 50 mg", "alcohol dependence", "opioid antagonist", "Naltrexone is easy to administer", "opioid- or alcohol-related health issues", "NALTREXONE 50" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6937c2a25e5aca52da7cb29f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Favipiravir 200mg", "description": "Favipiravir 200mg is an antiviral medication widely used to treat viral infections, particularly those caused by RNA viruses. It has gained significant attention in recent years as a promising therapeutic agent, especially during viral outbreaks such as influenza and more recently, COVID-19. This detailed description covers the product overview, its uses, key benefits, potential side effects, and a concluding summary to help users better understand Favipiravir 200mg.\n\nProduct Description\nFavipiravir belongs to a class of antiviral drugs that inhibit the replication of RNA viruses by targeting viral RNA-dependent RNA polymerase—an enzyme vital for viral replication. The 200mg dosage formulation is designed for oral administration and is typically available as film-coated tablets. The drug works by interfering with the viral genome synthesis process, thereby limiting the ability of viruses to multiply and spread in the body.\n\nOriginally developed and approved in Japan for the treatment of novel influenza strains, Favipiravir has since been explored and authorized in multiple countries for off-label or emergency use against other viral infections, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).\n\nUses of Favipiravir 200mg\nFavipiravir is primarily used as an antiviral treatment for infections caused by RNA viruses. Its key applications include:\n\nInfluenza Treatment: Favipiravir is effective against various strains of influenza viruses, especially when other antiviral medications prove less effective due to resistance or outbreak severity.\n\nCOVID-19 Management: During the COVID-19 pandemic, Favipiravir was rapidly adopted as part of many treatment protocols globally. It is used to manage mild to moderate COVID-19 cases by reducing viral load and accelerating recovery time.\n\nEmerging Viral Diseases: Favipiravir’s broad-spectrum antiviral activity makes it a potential treatment for other emerging RNA virus outbreaks, including Ebola, Lassa fever, and other viral hemorrhagic fevers.\n\nThe drug is typically prescribed by healthcare professionals after confirmed diagnosis and assessment of viral infection severity. Treatment duration and dosage depend on the specific infection and patient profile.\n\nKey Benefits of Favipiravir 200mg\nFavipiravir offers several important benefits that contribute to its growing role in viral infection management:\n\nBroad-Spectrum Antiviral Activity: Favipiravir targets a wide array of RNA viruses, making it versatile for treating multiple infections beyond influenza.\n\nOral Administration: Its oral tablet form facilitates ease of use in outpatient settings, reducing the burden on hospital resources and enabling home-based treatment.\n\nRapid Viral Load Reduction: Clinical studies indicate that Favipiravir can significantly decrease viral replication rates, thereby reducing the duration and severity of symptoms.\n\nPotential to Limit Disease Progression: Early treatment with Favipiravir may prevent progression to severe disease stages, especially in viral respiratory infections such as COVID-19.\n\nEmergency and Compassionate Use Flexibility: During health crises, Favipiravir has been approved under emergency use protocols, making it accessible when other options are limited.\n\nPotential Side Effects of Favipiravir 200mg\nWhile Favipiravir is generally well-tolerated, users should be aware of possible side effects. Reported adverse effects range from mild to moderate in severity and often resolve after treatment completion:\n\nGastrointestinal Disturbances: Nausea, vomiting, diarrhea, and abdominal discomfort may occur but are usually transient.\n\nElevated Liver Enzymes: Temporary increases in liver function tests have been reported, necessitating monitoring especially in patients with preexisting liver conditions.\n\nElevated Uric Acid Levels: Favipiravir can cause hyperuricemia; monitoring uric acid levels is advisable during treatment.\n\nHypersensitivity Reactions: Rare cases of allergic reactions, including rash, itching, or swelling, have been documented.\n\nTeratogenicity and Contraindications in Pregnancy: Favipiravir is contraindicated in pregnant women or those planning pregnancy due to potential risks of fetal harm observed in animal studies.\n\nPatients should inform their healthcare providers of all preexisting conditions and concomitant medications to avoid drug interactions and complications. Routine blood tests may be conducted to monitor liver function and uric acid levels during therapy.\n\nConclusion\nFavipiravir 200mg serves as a vital antiviral agent with broad-spectrum activity against RNA viruses, playing a significant role in managing viral infections like influenza and COVID-19. Its ability to reduce viral replication rapidly and its oral administration mode make it a convenient and effective option, particularly in outpatient or emergency settings. While side effects are generally manageable, careful patient monitoring ensures safe use, especially in vulnerable populations.\n\nAs viral epidemics and pandemics continue to challenge global health, Favipiravir remains an important therapeutic tool, helping to curb disease progression and improve patient outcomes. Consulting a healthcare professional before starting Favipiravir treatment is essential to determine appropriateness, dosage, and duration based on individual health status and specific viral infection.", "price": 1786.0, "discountamount": 536.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2238, "imageuri": "https://productimages.withfloats.com/actual/6937c2a56743e47449a24df1.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/6937c2a56743e47449a24df1.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-09T06:33:06.62Z", "updatedon": "2025-12-09T06:33:06.62Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/favipiravir-200mg/2238", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "FAVIPRIVE 200", "category": "GENERAL RANGE", "tags": [ "Favipiravir 200mg", "RNA viruses", "Favipiravir 200mg", "COVID-19", "respiratory syndrome coronavirus 2 (SARS-CoV-2).", "Favipiravir targets a wide array of RNA viruses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "692ebab58b1b9a33636fefc6", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Polmacoxib 2mg", "description": "Polmacoxib 2 mg capsules represent a targeted selective COX-2 inhibitor designed specifically for managing pain and inflammation in conditions like osteoarthritis, rheumatoid arthritis, and chronic joint issues. Each capsule delivers 2 mg of Polmacoxib, offering once-daily dosing for convenient, long-term use with a reduced risk of gastrointestinal complications compared to traditional NSAIDs. This formulation supports joint health by inhibiting the COX-2 enzyme responsible for producing prostaglandins that trigger pain, swelling, and stiffness.​\nTherapeutic Uses of Polmacoxib 2mg\nPolmacoxib 2 mg excels in treating osteoarthritis of the hip and knee, where cartilage breakdown leads to joint pain and reduced mobility. Healthcare providers prescribe it to alleviate symptoms of rheumatoid arthritis, ankylosing spondylitis, acute injuries like sprains, postoperative swelling, and chronic inflammatory disorders. By focusing on inflammation at its source, it helps patients regain daily functionality, from walking without stiffness to performing routine tasks with less discomfort.​\nThe medication proves particularly valuable for active individuals or those in later years seeking mobility support. It addresses post-surgery inflammation and muscle strains by quickly reducing localized swelling and pain, promoting faster recovery. Standard administration involves one 2mg capsule daily, with or without food, as directed by a physician to optimize absorption and efficacy.​\nKey Benefits and Advantages\nPolmacoxib 2mg stands out for its selective COX-2 inhibition, sparing the COX-1 enzyme that protects the stomach lining, thus minimizing risks like ulcers and bleeding common in non-selective NSAIDs. Patients experience rapid pain relief alongside improved joint flexibility, enabling better movement and reduced stiffness for enhanced quality of life.​\n\nEffective inflammation control targets swelling in osteoarthritis and rheumatoid arthritis, preserving cartilage and supporting long-term joint function.​\n\nLower gastrointestinal risks make it suitable for extended use, ideal for chronic conditions without frequent stomach upset.​\n\nConvenient once-daily dosing boosts adherence, while potential cardiovascular safety offers reassurance for those with heart concerns when used appropriately.​\n\nPromotes mobility in aging populations, reducing wear on joints and aiding independence during daily activities.​\n\nCompared to older NSAIDs, Polmacoxib provides comparable efficacy with a safer profile for prolonged therapy.​\n\nPotential Side Effects and Precautions\nWhile generally well-tolerated, Polmacoxib 2mg may cause common mild effects such as nausea, headache, dizziness, or stomach discomfort, which often resolve with continued use. Metabolic changes like elevated blood pressure can occur, especially in hypertensive patients, alongside rare renal issues or allergic reactions.​\n\nSerious risks, though less frequent, include cardiovascular events like heart attack or stroke with long-term high-dose use, particularly in those with pre-existing heart disease, and potential kidney impairment. Contraindications cover third-trimester pregnancy, severe heart or kidney conditions, and allergies to NSAIDs; interactions with blood thinners, diuretics, or ACE inhibitors require monitoring. Always consult a doctor before starting, especially if combining with other medications.​\n\nAspect\tCommon Side Effects\tSerious Risks\tPrecautions\nGastrointestinal\tNausea, upset stomach\tUlcers (reduced risk)\tTake with food if needed ​\nCardiovascular\tBlood pressure rise\tHeart attack, stroke\tMonitor in heart patients ​\nRenal\tMild changes\tKidney failure (rare)\tHydrate well ​\nGeneral\tHeadache, dizziness\tAllergic reactions\tAvoid alcohol ​\nDosage Guidelines and Best Practices\nAdults typically take one 2 mg capsule once daily for osteoarthritis or related pains, adjusting based on response and tolerance under medical supervision. Swallow whole without crushing; maintain consistent timing for steady relief. For acute pain, relief starts within hours, while chronic benefits build over days.​\n\nDo not exceed the prescribed dose to avoid amplified risks. Regular checkups ensure safety, particularly for long-term users. Store in a cool, dry place away from children.​\n\nConclusion: Empower Your Joint Health with Polmacoxib 2 mg\nPolmacoxib 2 mg capsules deliver precise, effective relief for osteoarthritis, rheumatoid arthritis, and inflammatory pains, balancing potent COX-2 inhibition with a favorable safety profile for sustained use. By easing pain, curbing inflammation, and enhancing mobility, it empowers patients to reclaim active lifestyles with fewer compromises. Consult healthcare professionals for personalized advice to maximize benefits while managing risks effectively.", "price": 180.0, "discountamount": 54.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2225, "imageuri": "https://productimages.withfloats.com/actual/692ebabc525aa88c1a67d995.png", "tileimageuri": "https://productimages.withfloats.com/tile/692ebabc525aa88c1a67d995.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-02T10:08:53.463Z", "updatedon": "2025-12-02T10:58:00.188Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/polmacoxib-2mg/2225", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PUMACOXIB 2 MG", "category": "", "tags": [ "Polmacoxib 2mg", "chronic joint issues", "COX-2 enzymes", "osteoarthritis of the hip and knee", "Joint Health with Polmacoxib 2 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69299814dd213181136f04b2", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Rosuvastatin and Clopidogrel Capsules", "description": "Rosuvastatin and Clopidogrel Capsules is a potent combination medication designed to manage and prevent cardiovascular diseases by targeting two critical factors: cholesterol levels and blood clot formation. This combination is particularly recommended for patients at high risk of heart attacks, strokes, or those with existing cardiovascular conditions. By integrating the lipid-lowering benefits of rosuvastatin with the antiplatelet action of clopidogrel, these capsules provide a dual mechanism of action aimed at improving cardiovascular health and reducing potentially life-threatening events.\n\nUses:\nRosuvastatin and Clopidogrel Capsules are primarily used for:\n\nControlling high cholesterol levels, especially reducing low-density lipoprotein (LDL) and triglycerides while increasing high-density lipoprotein (HDL).\n\nPreventing blood clot formation (thrombosis) by inhibiting platelet aggregation, which significantly lowers the risk of heart attacks and strokes.\n\nSlowing the progression of atherosclerosis (plaque buildup in arteries), helping to maintain open blood vessels for improved blood flow.\n\nManaging conditions like coronary artery disease, peripheral artery disease, and after procedures such as angioplasty or bypass surgery to reduce recurrent cardiovascular events.\n\nKey Benefits:\n\nCombined efficacy in lowering cholesterol and preventing clot-related complications contributes to reduced cardiovascular morbidity and mortality.\n\nImproved blood flow achieved by preventing arterial blockages and promoting vascular health.\n\nStabilization of cholesterol plaques in arteries, reducing their risk of rupture.\n\nProtection against acute coronary syndromes and ischemic stroke.\n\nEnhances long-term cardiovascular outcomes in high-risk patients through a synergistic effect of both drugs.\nConvenient oral capsule form encourages patient adherence to prescribed regimens.\nSide Effects:\nWhile generally well tolerated, Rosuvastatin and Clopidogrel Capsules may cause side effects. Common side effects include headache, dizziness, gastrointestinal disturbances such as nausea or abdominal pain, and muscle aches. Patients might experience fatigue or weakness occasionally.\n\nSerious side effects are less frequent but require immediate medical attention. These include severe muscle pain or tenderness (a sign of rhabdomyolysis), allergic reactions, unusual bleeding or bruising (due to clopidogrel’s blood-thinning effects), liver dysfunction, and signs of an infection such as fever or chills. Regular monitoring of liver function tests, blood counts, and muscle-related symptoms is essential during therapy.\n\nConclusion:\nRosuvastatin and Clopidogrel Capsules serve as a comprehensive therapeutic approach for patients with cardiovascular diseases by simultaneously addressing two major risk factors: elevated cholesterol and thrombus formation. Their combined use reduces the risk of heart attacks, strokes, and other severe cardiovascular events while promoting healthier blood flow and vascular function. Adherence to prescribed dosages and periodic medical evaluations will maximize the benefits while minimizing side effect risks. Always consult healthcare professionals before starting or stopping therapy to ensure safety and effectiveness.", "price": 173.0, "discountamount": 52.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2223, "imageuri": "https://productimages.withfloats.com/actual/6929981653223ab539492563.png", "tileimageuri": "https://productimages.withfloats.com/tile/6929981653223ab539492563.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-11-28T12:39:48.689Z", "updatedon": "2025-12-11T10:11:13.678Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/rosuvastatin-and-clopidogrel-capsules/2223", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ROUSTRIN CV 10", "category": "cardiology", "tags": [ "Rosuvastatin and Clopidogrel Capsules", "cardiovascular diseases", "heart attacks", "cardiovascular conditions" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69282c091a6e5ed700f07fe1", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Lurasidone Hydrochloride Tablets 40 mg", "description": "Lurasidone Hydrochloride Tablets 40 mg are an atypical antipsychotic medication primarily prescribed for the treatment of schizophrenia and bipolar disorder, including depressive episodes associated with bipolar I disorder. Manufactured to deliver precise dosing, these tablets help manage symptoms such as hallucinations, delusions, mood swings, and depression by modulating the activity of certain neurotransmitters in the brain. Lurasidone works by balancing dopamine and serotonin receptors, which are often dysregulated in psychiatric conditions, thereby improving thought processes, mood stability, and overall mental function.\nKey Benefits of Lurasidone Hydrochloride Tablets 40 mg\nEffective control of schizophrenia symptoms such as delusions, hallucinations, and disorganized thinking.\nTreatment of major depressive episodes in bipolar I disorder either as monotherapy or adjunctive therapy with lithium or valproate.\nImprovement in mood stabilization helps reduce manic and depressive episodes in bipolar patients.\nGenerally improved patient quality of life by reducing the severity of psychotic and mood symptoms.\nSuitable for adult patients as well as adolescents aged 13 years and older for schizophrenia and patients 10 years and older for bipolar depression under medical guidance.\nFlexible dosing options allow for titration based on clinical response and tolerability.\nSide Effects of Lurasidone Hydrochloride Tablets 40 mg\nLike many antipsychotic medications, Lurasidone may cause side effects, some of which are mild and manageable, while others may require medical attention. Common side effects include nausea, dizziness, restlessness, sedation, weight gain, and gastrointestinal issues such as vomiting or constipation. Some patients may experience extrapyramidal symptoms, which affect muscle control and movement, such as tremors or rigidity. Blood sugar and lipid levels may rise, so periodic monitoring is advised.\nSerious side effects, though less common, can include neuroleptic malignant syndrome (a rare but severe neurological disorder), tardive dyskinesia (involuntary muscle movements), and metabolic changes like significant weight gain, hyperglycemia, or elevated cholesterol. Allergic reactions are rare but possible and require immediate medical attention.\n\nConclusion\n\nLurasidone Hydrochloride Tablets 40 mg offer significant benefits for patients struggling with schizophrenia and bipolar depression by addressing psychotic symptoms and mood disturbances through targeted neurotransmitter modulation. Its efficacy in improving mental health and quality of life is well-documented, but careful adherence to prescribed dosages and medical supervision are essential due to potential side effects. Regular monitoring and open communication with healthcare providers help ensure that patients receive the maximum therapeutic benefit while minimizing risks. This medication should always be used under the guidance of a qualified healthcare professional.", "price": 280.0, "discountamount": 84.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2222, "imageuri": "https://productimages.withfloats.com/actual/69282c0bb521bb4f16017ce2.png", "tileimageuri": "https://productimages.withfloats.com/tile/69282c0bb521bb4f16017ce2.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-11-27T10:46:33.864Z", "updatedon": "2025-12-01T09:14:37.234Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/lurasidone-hydrochloride-tablets-40-mg/2222", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LURASINODE 40", "category": "", "tags": [ "Lurasidone Hydrochloride Tablets 40 mg", "schizophrenia and bipolar disorder", "Lurasidone", "bipolar I disorder" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "692828993056ad8a5a1abc7c", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Rizatriptan Benzoate 5 mg", "description": "Rizatriptan Benzoate 5 mg is a specialized medication widely used for the acute treatment of migraine headaches, including migraines with or without aura. It belongs to the triptan class of drugs, which work as selective serotonin receptor agonists targeting 5-HT1B and 5-HT1D receptors in the brain. By stimulating these receptors, rizatriptan benzoate helps to narrow dilated blood vessels in the brain and reduce inflammation, which are key contributors to migraine pain and associated symptoms.\n\nThe primary use of Rizatriptan Benzoate 5 mg is to relieve migraine attacks once they begin. It is clinically proven to reduce headache pain, sensitivity to light and sound, and other migraine-associated symptoms such as nausea and visual disturbances. This medication is effective in both adult patients and pediatric patients aged 6 to 17 years. It is important to note that rizatriptan is not indicated for the prevention of migraines or for the treatment of certain other types of headaches, such as cluster headaches or hemiplegic/basilar migraines.\n\nKey benefits of Rizatriptan Benzoate 5 mg include its rapid onset of action and targeted mechanism for migraine relief. Patients often experience significant headache improvement within 2 hours of taking the dose. The drug’s specificity for serotonin receptors in cerebral blood vessels helps minimize systemic side effects often seen with other pain medications. Rizatriptan’s effectiveness also extends to pediatric patients, providing migraine relief for children and adolescents, which is an important advantage in this age group.\n\nDespite its benefits, Rizatriptan Benzoate 5 mg may cause some side effects. Common side effects include dizziness, drowsiness, dry mouth, fatigue, and sensations of warmth or flushing. Some patients may also experience nausea or mild abdominal discomfort. These side effects are usually mild and transient. Serious side effects are rare but can include chest pain or tightness, irregular heartbeats, or signs of allergic reactions such as rash, swelling, or difficulty breathing. If any severe symptoms occur, immediate medical attention is necessary.\n\nPatients with certain cardiovascular conditions, uncontrolled high blood pressure, or ischemic heart disease should avoid rizatriptan due to its vasoconstrictive effects. Additionally, it should be avoided in patients using monoamine oxidase inhibitors (MAOIs) or other serotonergic drugs to prevent serious drug interactions.\nIn conclusion, Rizatriptan Benzoate 5 mg is an effective and targeted medication for the acute relief of migraine attacks in both adults and children. Its fast action and specific receptor targeting provide quick symptom relief with a relatively favorable safety profile when used as directed. Awareness of its potential side effects and contraindications ensures safe use under medical supervision, making rizatriptan a valuable option in migraine management.", "price": 420.0, "discountamount": 126.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2221, "imageuri": "https://productimages.withfloats.com/actual/692828a5b42569edb67be924.png", "tileimageuri": "https://productimages.withfloats.com/tile/692828a5b42569edb67be924.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-11-27T10:31:53.187Z", "updatedon": "2025-12-09T10:16:15.65Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/rizatriptan-benzoate-5-mg/2221", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "RIZONITIME 5", "category": "NEUROLOGY", "tags": [ "Rizatriptan Benzoate 5 mg", "migraine headaches", "Rizatriptan Benzoate 5 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }